KEGG   ORTHOLOGY: K17683
Entry
K17683            Tight     KO                                     
Symbol
CYP2A6
Name
cytochrome P450 family 2 subfamily A6 [EC:1.14.14.-]
Pathway
map00232  Caffeine metabolism
map00830  Retinol metabolism
map00980  Metabolism of xenobiotics by cytochrome P450
map00982  Drug metabolism - cytochrome P450
map00983  Drug metabolism - other enzymes
map01100  Metabolic pathways
map05204  Chemical carcinogenesis - DNA adducts
map05417  Lipid and atherosclerosis
Reaction
R07000  naphthalene,NADPH:oxygen oxidoreductase (RH-hydroxylating or -epoxidizing)
R07001  naphthalene,NADPH:oxygen oxidoreductase (RH-hydroxylating or -epoxidizing)
R07945  
R08225  
R08324  
R08325  
R08326  
R08327  
R08390  
R08391  
R08392  
R09408  
R09421  
R09423  
R09424  
R09425  
Disease
H01205  Coumarin resistance
Brite
KEGG Orthology (KO) [BR:ko00001]
 09100 Metabolism
  09108 Metabolism of cofactors and vitamins
   00830 Retinol metabolism
    K17683  CYP2A6; cytochrome P450 family 2 subfamily A6
  09110 Biosynthesis of other secondary metabolites
   00232 Caffeine metabolism
    K17683  CYP2A6; cytochrome P450 family 2 subfamily A6
  09111 Xenobiotics biodegradation and metabolism
   00980 Metabolism of xenobiotics by cytochrome P450
    K17683  CYP2A6; cytochrome P450 family 2 subfamily A6
   00982 Drug metabolism - cytochrome P450
    K17683  CYP2A6; cytochrome P450 family 2 subfamily A6
   00983 Drug metabolism - other enzymes
    K17683  CYP2A6; cytochrome P450 family 2 subfamily A6
 09160 Human Diseases
  09161 Cancer: overview
   05204 Chemical carcinogenesis - DNA adducts
    K17683  CYP2A6; cytochrome P450 family 2 subfamily A6
  09166 Cardiovascular disease
   05417 Lipid and atherosclerosis
    K17683  CYP2A6; cytochrome P450 family 2 subfamily A6
 09180 Brite Hierarchies
  09181 Protein families: metabolism
   00199 Cytochrome P450
    K17683  CYP2A6; cytochrome P450 family 2 subfamily A6
Cytochrome P450 [BR:ko00199]
 Cytochrome P450, animal type
  CYP2 family
   K17683  CYP2A6; cytochrome P450 family 2 subfamily A6
Genes
HSA: 1548(CYP2A6) 1549(CYP2A7)
PTR: 107966456(CYP2A7)
PPS: 100975509(CYP2A7)
GGO: 101146638
PON: 100457048
PPYG: 129019418
MCF: 102122745(CYP2A24)
TGE: 112611969
PTEH: 111554025
Reference
PMID:2726448 (CYP2A6)
  Authors
Miles JS, Bickmore W, Brook JD, McLaren AW, Meehan R, Wolf CR
  Title
Close linkage of the human cytochrome P450IIA and P450IIB gene subfamilies: implications for the assignment of substrate specificity.
  Journal
Nucleic Acids Res 17:2907-17 (1989)
DOI:10.1093/nar/17.8.2907
  Sequence
[hsa:1548]
Reference
PMID:7668294 (CYP2A7)
  Authors
Fernandez-Salguero P, Hoffman SM, Cholerton S, Mohrenweiser H, Raunio H, Rautio A, Pelkonen O, Huang JD, Evans WE, Idle JR, et al.
  Title
A genetic polymorphism in coumarin 7-hydroxylation: sequence of the human CYP2A genes and identification of variant CYP2A6 alleles.
  Journal
Am J Hum Genet 57:651-60 (1995)
  Sequence
[hsa:1549]
Reference
  Authors
Xu C, Goodz S, Sellers EM, Tyndale RF
  Title
CYP2A6 genetic variation and potential consequences.
  Journal
Adv Drug Deliv Rev 54:1245-56 (2002)
DOI:10.1016/S0169-409X(02)00065-0

KEGG   ORTHOLOGY: K17685
Entry
K17685                      KO                                     
Symbol
CYP2A13
Name
cytochrome P450 family 2 subfamily A13 [EC:1.14.14.1]
Pathway
map00980  Metabolism of xenobiotics by cytochrome P450
map05204  Chemical carcinogenesis - DNA adducts
Reaction
R09406  
R09408  
R09421  
R09423  
R09424  
R09425  
Brite
KEGG Orthology (KO) [BR:ko00001]
 09100 Metabolism
  09111 Xenobiotics biodegradation and metabolism
   00980 Metabolism of xenobiotics by cytochrome P450
    K17685  CYP2A13; cytochrome P450 family 2 subfamily A13
 09160 Human Diseases
  09161 Cancer: overview
   05204 Chemical carcinogenesis - DNA adducts
    K17685  CYP2A13; cytochrome P450 family 2 subfamily A13
 09180 Brite Hierarchies
  09181 Protein families: metabolism
   00199 Cytochrome P450
    K17685  CYP2A13; cytochrome P450 family 2 subfamily A13
Enzymes [BR:ko01000]
 1. Oxidoreductases
  1.14  Acting on paired donors, with incorporation or reduction of molecular oxygen
   1.14.14  With reduced flavin or flavoprotein as one donor, and incorporation of one atom of oxygen into the other donor
    1.14.14.1  unspecific monooxygenase
     K17685  CYP2A13; cytochrome P450 family 2 subfamily A13
Cytochrome P450 [BR:ko00199]
 Cytochrome P450, animal type
  CYP2 family
   K17685  CYP2A13; cytochrome P450 family 2 subfamily A13
Genes
HSA: 1553(CYP2A13)
PTR: 101058187
PPS: 100982833(CYP2A13)
GGO: 101127384
PON: 100458875
PPYG: 129020009
NLE: 100579248 115830830
HMH: 116480658
SSYN: 129466953
MCC: 114674219 678689(CYP2A24) 678690(CYP2A23) 702954(CYP2A26) 722086
MCF: 102121341(CYP2A26) 102123758(CYP2A23) 102143277(CYP2A13)
PTEH: 111554024
CJC: 100399054(CYP2A7)
SBQ: 101046499
CIMI: 108285671(CYP2A6)
ANAN: 105723439(CYP2A6)
LCAT: 123624295
PCOQ: 105820478
PKL: 118730245
EFUS: 129149622
TOD: 119250434
CTIG: 120316367
APRI: 131204543
HCG: 128332693
STOW: 125424829
DPOL: 127863877
 » show all
Reference
  Authors
Su T, Bao Z, Zhang QY, Smith TJ, Hong JY, Ding X
  Title
Human cytochrome P450 CYP2A13: predominant expression in the respiratory tract and its high efficiency metabolic activation of a tobacco-specific carcinogen, 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone.
  Journal
Cancer Res 60:5074-9 (2000)
  Sequence
[hsa:1553]

DBGET integrated database retrieval system